MagForce AG supports NOA Winter School 2016 from December 01-02 in Münster, Germany - Seite 2
addition to the tumor ablation. In our poster presentation during the SNO
conference in November 2016, we reported about our data demonstrating that
the combination of modified NanoTherm therapy with radiotherapy can induce
a strong reaction at the resection cavity assuming that large amounts of
cellular debris are released in situ, which can serve as a source of tumor
antigens to elicit host CD8+ T-cell mediated adaptive immune responses
against the tumor. These are first observations indicating an immune
stimulatory effect of modified NanoTherm therapy in patients. We are very
excited about these observations and are aiming to continue investigating
this interesting effect during the treatment of further patients to
decipher the NanoTherm immune-related effects."
About the NOA Winter School 2016
NOA is the Neuro-Oncological Working Group within the German Cancer
Society. For the NOA Winter School 2016, renowned neuro-oncology
researchers and clinicians from all over Germany have been invited to share
their knowledge. Conference topics will include a wide variety of subjects
from advice on "how to deliver bad news" or "how do molecular markers
influence therapy decisions?" to "therapy options for meningeoma" to
"Medulloblastoma treatment in children and adults" as well as "current
developments in the field clinical studies" and "Gliom news". In addition
to presenting latest research results, the NOA Winter School is a platform
for exchange and discussion with individual experts and sharing
experiences.
About SNO 2016
The Society for Neuro-Oncology (SNO) is a multidisciplinary organization
dedicated to promoting advances in neuro-oncology through research and
education. Building upon the success of past SNO meetings, the 2016
Scientific Meeting featured concurrent and plenary sessions, highlighted by
focused minisymposia, oral abstract presentations, rapid reports, and
poster presentations. New this year were the enhanced e-talk poster
presentations, "Meet the Experts" and "SNO Daily Highlights" webcasts.
Special lunch tutorials and industry-sponsored symposia provided in-depth
information on a variety of timely issues impacting CNS tumor research and
treatment including the 2016 revision of the WHO classification of CNS
tumors and Epigenetics.
The Education Day focused on Precision Medicine and the new WHO
classification of CNS tumors and offered innovative and informative
presentations in Translational Science, Clinical and Applied Neuro-
Oncology. Highlights included mock integrative diagnostic and molecular
Society. For the NOA Winter School 2016, renowned neuro-oncology
researchers and clinicians from all over Germany have been invited to share
their knowledge. Conference topics will include a wide variety of subjects
from advice on "how to deliver bad news" or "how do molecular markers
influence therapy decisions?" to "therapy options for meningeoma" to
"Medulloblastoma treatment in children and adults" as well as "current
developments in the field clinical studies" and "Gliom news". In addition
to presenting latest research results, the NOA Winter School is a platform
for exchange and discussion with individual experts and sharing
experiences.
About SNO 2016
The Society for Neuro-Oncology (SNO) is a multidisciplinary organization
dedicated to promoting advances in neuro-oncology through research and
education. Building upon the success of past SNO meetings, the 2016
Scientific Meeting featured concurrent and plenary sessions, highlighted by
focused minisymposia, oral abstract presentations, rapid reports, and
poster presentations. New this year were the enhanced e-talk poster
presentations, "Meet the Experts" and "SNO Daily Highlights" webcasts.
Special lunch tutorials and industry-sponsored symposia provided in-depth
information on a variety of timely issues impacting CNS tumor research and
treatment including the 2016 revision of the WHO classification of CNS
tumors and Epigenetics.
The Education Day focused on Precision Medicine and the new WHO
classification of CNS tumors and offered innovative and informative
presentations in Translational Science, Clinical and Applied Neuro-
Oncology. Highlights included mock integrative diagnostic and molecular
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte